Skip to content
10-Q

Quarterly Report

ESTRELLA IMMUNOPHARMA, INC. ESLA ESLAW

0001213900-25-109198

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 37.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 37.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 36.49M sh
Shares Diluted Q3 2025 · Sep 30, 2024 36.21M sh
Shares Diluted Q3 2025 · Sep 30, 2024 36.19M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$1.61M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$6.74M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.63M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $916.92K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$9.84M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$6.09M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$1.83M
Stockholders Equity Q3 2025 · Dec 31, 2024 $143.73K
Stockholders Equity Q3 2025 · Sep 30, 2024 $746.29K
Stockholders Equity Q3 2025 · Jun 30, 2024 $4.27M
Stockholders Equity Q3 2025 · Mar 31, 2024 $8.49M
Stockholders Equity Q3 2025 · Dec 31, 2023 $9.05M
Current Liabilities Q3 2025 · Sep 30, 2025 $13.36M
Current Liabilities Q3 2025 · Dec 31, 2024 $3M
Total Liabilities Q3 2025 · Sep 30, 2025 $13.36M
Total Liabilities Q3 2025 · Dec 31, 2024 $3M
Current Assets Q3 2025 · Sep 30, 2025 $2.02M
Current Assets Q3 2025 · Dec 31, 2024 $1.64M
Total Assets Q3 2025 · Sep 30, 2025 $3.52M
Total Assets Q3 2025 · Dec 31, 2024 $3.14M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.34
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.09
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.34
Eps Basic Q3 2025 · Sep 30, 2024 −$0.09
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Sga Expense Q3 2025 · Sep 30, 2025 $648.51K
Sga Expense Q3 2025 · Sep 30, 2025 $2.23M
Sga Expense Q3 2025 · Sep 30, 2024 $550.74K
Sga Expense Q3 2025 · Sep 30, 2024 $1.42M
Rd Expense Q3 2025 · Sep 30, 2025 $4.15M
Rd Expense Q3 2025 · Sep 30, 2025 $10.22M
Rd Expense Q3 2025 · Sep 30, 2024 $2.83M
Rd Expense Q3 2025 · Sep 30, 2024 $6.38M
Net Income Q3 2025 · Sep 30, 2025 −$4.8M
Net Income Q3 2025 · Sep 30, 2025 −$12.45M
Net Income Q3 2025 · Jun 30, 2025 −$5.54M
Net Income Q3 2025 · Mar 31, 2025 −$2.1M
Net Income Q3 2025 · Sep 30, 2024 −$3.38M
Net Income Q3 2025 · Sep 30, 2024 −$7.8M
Net Income Q3 2025 · Jun 30, 2024 −$3.95M
Net Income Q3 2025 · Mar 31, 2024 −$469.53K
Operating Income Q3 2025 · Sep 30, 2025 −$4.8M
Operating Income Q3 2025 · Sep 30, 2025 −$12.45M
Operating Income Q3 2025 · Sep 30, 2024 −$3.38M
Operating Income Q3 2025 · Sep 30, 2024 −$7.8M
Stock Repurchased Q3 2025 · Jan 30, 2024 $1M